These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9458435)

  • 1. The amiodarone trials.
    Julian DG
    Eur Heart J; 1997 Sep; 18(9):1361-2. PubMed ID: 9458435
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 3. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Malik M; Camm AJ
    Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398
    [No Abstract]   [Full Text] [Related]  

  • 4. Amiodarone and mortality in CHF and post-MI.
    Zamorski M
    J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
    Hlatky MA; Owens DK
    J Am Coll Cardiol; 1998 Jun; 31(7):1490-2. PubMed ID: 9626824
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiarrhythmic treatment and myocardial infarction.
    Keung EC
    J Am Coll Cardiol; 1990 Dec; 16(7):1719-21. PubMed ID: 2254559
    [No Abstract]   [Full Text] [Related]  

  • 9. Arrhythmia suppression in postmyocardial infarction patients with special notation to cardiac arrhythmia suppression trial.
    Gheorghiade M; Goldstein S
    Prog Cardiovasc Dis; 1991; 33(4):213-8. PubMed ID: 1994455
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
    Cairns JA
    Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
    Funck-Brentano C
    Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack.
    Ann Intern Med; 2001 Nov; 135(10):S-56. PubMed ID: 11757494
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SWORD of Damocles.
    Sanderson J
    Lancet; 1996 Jul; 348(9019):2-3. PubMed ID: 8691925
    [No Abstract]   [Full Text] [Related]  

  • 16. Should post-infarction asymptomatic ventricular arrhythmias be treated? The need for caution.
    Sleight P
    Eur Heart J; 1995 Jul; 16 Suppl E():49. PubMed ID: 8542884
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Pinski SL
    Lancet; 1997 Jun; 349(9067):1768-9; author reply 1769-70. PubMed ID: 9193400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
    Werkö L
    Lakartidningen; 1998 Jan; 95(4):246-8. PubMed ID: 9469947
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
    Kennedy HL
    Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.